Abstract

Chemical tools that allow the real-time monitoring of organ function and the visualisation of organ-related processes at the cellular level are of great importance in biological research. The upregulation/downregulation of specific biomarkers is often associated with the development of organ related diseases. Small-molecule fluorescent probes have the potential to create advances in our understanding of these disorders. Viable probes should be endowed with a number of key features that include high biomarker sensitivity, low limit of detection, fast response times and appropriate in vitro and in vivo biocompatibility. In this tutorial review, we discuss the development of probes that allow the targeting of organ related processes in vitro and in vivo. We highlight the design strategy that underlies the preparation of various promising probes, their optical response to key biomarkers, and proof-of-concept biological studies. The inherent drawbacks and limitations are discussed as are the current challenges and opportunities in the field. The hope is that this tutorial review will inspire the further development of small-molecule fluorescent probes that could aid the study of pathogenic conditions that contribute to organ-related diseases.

Highlights

  • The human body contains multiple major organs, all of which are crucial to maintaining healthy function.Each major organ plays a specific role in the body; synergy between various major organs is required for optimal health

  • Reaction with GSH catalysed by glutathione S-transferase p (GSTp) that is overexpressed in various tumour cells leads to formation of a covalently bound adduct that can react further with sulfhydryl groups present in a variety of tumour proteins to produce an anti-tumour effect (Fig. 31)

  • Monitoring the onset and progression of diseases related to major organs, as well as differentiating acute and chronic forms of the same diseases, is beneficial

Read more

Summary

Introduction

The human body contains multiple major organs (cf. Scheme 1a), all of which are crucial to maintaining healthy function. His research interests in the development of new fluorescent probes for disease diagnosis and active analyte detection He Tian Jr. is a PhD student in Applied Chemistry under the supervision of Prof. Which are designed to bind/react with a target disease-based biomarker and provide a measurable change to the fluorescence signal These small molecule-based fluorescent probes should have high sensitivity and specificity for their target analyte to ensure its accurate detection within a biological system. The design of effective small molecule-based fluorescent probes for interrogating and evaluating the development of major organ disease should meet the following requirements: significant signal change before and after biomarker recognition, fluorophore with good photostability, high fluorescence quantum yield, adequate water solubility, cell permeability and acceptable biocompatibility. More than one strategy may be employed; in others, the design of effective probes remains an unmet need that would benefit from further research and development efforts

Small molecule-based fluorescent probes for brain diseases
Small molecule-based fluorescent probes for Alzheimer’s disease
Small molecule-based fluorescent probes for Parkinson’s disease
Small molecule-based fluorescent probes for epilepsy
Small molecule-based fluorescent probes for depression
Small molecule-based fluorescent probes for liver disease
Small molecule-based fluorescent probes for liver fibrosis
Small molecule-based fluorescent probes for kidney disease
Small molecule-based fluorescent probes for kidney dysfunction
Small molecule-based fluorescent probes for acute kidney injury
Small molecule-based fluorescent probes for lung disease
Small molecule-based fluorescent probes for lung inflammation
Small molecule-based fluorescent probes for pulmonary fibrosis
Small molecule-based fluorescent probes for lung cancer
Small molecule-based fluorescent probes for colitis
Small molecule-based fluorescent probes for gastric cancer
Small molecule-based fluorescent probes for heart disease
Small molecule-based fluorescent probes for myocardial fibrosis
Small molecule-based fluorescent probes for drug-induced cardiotoxicity
Findings
Conclusion and outlook
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.